Literature DB >> 1861629

Enhanced in vitro oxidation of plasma lipoproteins derived from hypercholesterolemic patients.

A Lavy1, G J Brook, G Dankner, A Ben Amotz, M Aviram.   

Abstract

In vitro oxidation of plasma lipoproteins, derived from either normolipidemic or hypercholesterolemic subjects, was performed in the presence of copper ions. Following this procedure, hypercholesterolemic low-density lipoprotein (LDL), very-low-density lipoprotein (VLDL), and high-density lipoprotein (HDL) demonstrated greater propensity for oxidation than the corresponding normocholesterolemic lipoproteins. The oxidation was determined by the concentration of thiobarbituric acid-reactive substances (TBARS), which was 44%, 71%, and 54% greater in the patients' VLDL, LDL, and HDL in comparison to the normocholesterolemic lipoproteins, respectively. An associated reduction in trinitrobenzensulfonic acid (TNBS) reactivity in the patients' lipoproteins was noted. These changes were consistent whether expressed per lipoprotein protein or per concentration. Macrophage cholesterol esterification induced by oxidized LDL was substantially increased (up to 59%) when patients' lipoproteins were used, in comparison to control lipoproteins. A positive correlation was present between the LDL cholesterol to protein ratio, the extent of lipoprotein oxidation, and macrophage uptake of the oxidized lipoproteins. The lipoprotein content of pro-oxidant and antioxidant constituents was also analyzed. No measurable ferric or copper ions could be found in association with any of the lipoproteins. However, arachidonic acid content of the patients' LDL was 10.1% +/- 1.0% in comparison to 6.2% +/- 0.8% of total lipoprotein fatty acids in the control group (n = 5). Antioxidants such as vitamin E and carotenoids were significantly reduced in all patients' lipoproteins compared with those of controls. Thus, we suggest that increased cholesterol and arachidonic acid content and reduced concentration of antioxidants in lipoproteins of hypercholesterolemic patients may be responsible for the enhanced propensity for oxidation observed in these lipoproteins.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1861629     DOI: 10.1016/0026-0495(91)90005-h

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  14 in total

1.  Response of plasma lipids to dietary cholesterol and wine polyphenols in rats fed polyunsaturated fat diets.

Authors:  L Frémont; M T Gozzelino; A Linard
Journal:  Lipids       Date:  2000-09       Impact factor: 1.880

2.  Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer's disease and are neurotoxic when oxidized ex vivo.

Authors:  C N Bassett; M D Neely; K R Sidell; W R Markesbery; L L Swift; T J Montine
Journal:  Lipids       Date:  1999-12       Impact factor: 1.880

Review 3.  The postprandial effects of dietary antioxidants in humans.

Authors:  Colin D Kay; Bruce J Holub
Journal:  Curr Atheroscler Rep       Date:  2003-11       Impact factor: 5.113

4.  Effects of policosanol treatment on the susceptibility of low density lipoprotein (LDL) isolated from healthy volunteers to oxidative modification in vitro.

Authors:  R Menéndez; R Más; A M Amor; R M González; J C Fernández; I Rodeiro; M Zayas; S Jiménez
Journal:  Br J Clin Pharmacol       Date:  2000-09       Impact factor: 4.335

Review 5.  LDL oxidation by arterial wall macrophages depends on the oxidative status in the lipoprotein and in the cells: role of prooxidants vs. antioxidants.

Authors:  M Aviram; B Fuhrman
Journal:  Mol Cell Biochem       Date:  1998-11       Impact factor: 3.396

Review 6.  Why are low-density lipoproteins atherogenic?

Authors:  S G Young; S Parthasarathy
Journal:  West J Med       Date:  1994-02

7.  Selenium level is associated with apoE epsilon4 in rural elderly Chinese.

Authors:  Sujuan Gao; Yinlong Jin; Kathleen S Hall; Chaoke Liang; Frederick W Unverzagt; Feng Ma; Yibin Cheng; Jianzhao Shen; Jingxiang Cao; Janetta Matesan; Ping Li; Jianchao Bian; Hugh C Hendrie; Jill R Murrell
Journal:  Public Health Nutr       Date:  2009-03-12       Impact factor: 4.022

8.  Effects of ACE inhibitors on oxidation of human low density lipoprotein.

Authors:  E G Godfrey; J Stewart; H J Dargie; J L Reid; M Dominiczak; C A Hamilton; J McMurray
Journal:  Br J Clin Pharmacol       Date:  1994-01       Impact factor: 4.335

9.  Kinetic analysis of LDL oxidation in IHD and IHD risk subjects in Indian population.

Authors:  Yashika Gupta; V Mallika; D K Srivastava
Journal:  Indian J Clin Biochem       Date:  2003-01

10.  Ezetimibe's effect on platelet aggregation and LDL tendency to peroxidation in hypercholesterolaemia as monotherapy or in addition to simvastatin.

Authors:  Osamah Hussein; Lilia Minasian; Yaroslav Itzkovich; Karina Shestatski; Lizora Solomon; Jamal Zidan
Journal:  Br J Clin Pharmacol       Date:  2008-01-30       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.